Scholarlink

Background <p><i>PAX2</i> encodes a transcription factor critical for kidney development. Pathogenic <i>PAX2</i> variants are associated with heterogeneous kidney and extrarenal manifestations. However, the clinical heterogeneity of PAX2-associated kidney disease and the functional consequences of newly identified variants remain incompletely characterized in pediatric cohorts.</p> Methods <p>We retrospectively analyzed probands from a single-center pediatric genetic kidney disease program (2018–2024). Clinical data, imaging, kidney pathology, follow-up kidney function and genetic results were reviewed. Selected variants were functionally assessed in HEK293 cells using protein expression, cycloheximide-chase, and dual-luciferase reporter assays.</p> Results <p>We identified 14 distinct <i>PAX2</i> variants in 15 probands, including seven previously unreported variants: p.D2Y, p.T210A, p.S242N, p.V206D, p.A160T, p.F256Ffs*40, and p.L44_A45insV. The cohort showed substantial phenotypic heterogeneity, including variability in age at diagnosis, kidney manifestations, disease severity, extrarenal involvement, and intrafamilial expressivity. Kidney biopsy findings, available in seven patients, were heterogeneous and nonspecific. Functional analyses showed that several variants reduced PAX2 protein expression, impaired protein stability, and/or decreased transcriptional activity.</p> Conclusion <p>This study expands the clinical and molecular spectrum of <i>PAX2</i>-related kidney disease in Chinese children and highlights its substantial phenotypic and pathological heterogeneity. Early genetic testing, retrospective reanalysis, and longitudinal follow-up are valuable for children with unexplained kidney disease.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Novel PAX2 variants and phenotypic heterogeneity in pediatric kidney disease: a single-center retrospective study

  • 期刊论文

  • 发表日期：

    2026年7月30日

查看全文
  • Xingying Zhu,
  • Qian Liu,
  • Shumin He,
  • Bixia Zheng,
  • Chunli Wang,
  • Fei Zhao,
  • Guixia Ding,
  • Aihua Zhang,
  • Wei Zhou

摘要

Background

PAX2 encodes a transcription factor critical for kidney development. Pathogenic PAX2 variants are associated with heterogeneous kidney and extrarenal manifestations. However, the clinical heterogeneity of PAX2-associated kidney disease and the functional consequences of newly identified variants remain incompletely characterized in pediatric cohorts.

Methods

We retrospectively analyzed probands from a single-center pediatric genetic kidney disease program (2018–2024). Clinical data, imaging, kidney pathology, follow-up kidney function and genetic results were reviewed. Selected variants were functionally assessed in HEK293 cells using protein expression, cycloheximide-chase, and dual-luciferase reporter assays.

Results

We identified 14 distinct PAX2 variants in 15 probands, including seven previously unreported variants: p.D2Y, p.T210A, p.S242N, p.V206D, p.A160T, p.F256Ffs*40, and p.L44_A45insV. The cohort showed substantial phenotypic heterogeneity, including variability in age at diagnosis, kidney manifestations, disease severity, extrarenal involvement, and intrafamilial expressivity. Kidney biopsy findings, available in seven patients, were heterogeneous and nonspecific. Functional analyses showed that several variants reduced PAX2 protein expression, impaired protein stability, and/or decreased transcriptional activity.

Conclusion

This study expands the clinical and molecular spectrum of PAX2-related kidney disease in Chinese children and highlights its substantial phenotypic and pathological heterogeneity. Early genetic testing, retrospective reanalysis, and longitudinal follow-up are valuable for children with unexplained kidney disease.

Graphical abstract